Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Ranolazine PR in Healthy Korean and Caucasian Males
NCT02817932Phase 1Unknown
- Sponsor
- Menarini Group
- Start
- Mar 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ranolazine in Angina Pectoris (AP) (5 arms), sponsored by Menarini Group. Primary endpoint: Pharmacokinetic Assessment up to 5 days. Status: unknown.
02
Drugs
ranolazine
03
Conditions
Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT02817932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817932.